| Company Name: | Affymetrix, Inc. | | Ticker Symbol: | AFFX | | | WWW Address: | www.affymetrix.com |
| CEO: | Dr. Frank R. Witney,,PhD | | No. of Employees: | 1,100 |
| Common Issue Type: | CS | | Business Description: | Affymetrix, Inc., is a provider of life science tools and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level.
|
| | | Industry Information: | ELECTRONICS - Scientific & Technical Instruments [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 3.67 |  -0.06 | 3.2 | 3.75 | 3.74 | 3.76 | 3.69 | 353036 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 260.9 | 71.1 | 2.17 | -0.15 | 0.00 | 0.0 | 0.0 | 5.50 - 2.96 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 3.73 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 260.9 | mil |
| Latest Shares Outstanding | 71.1 | mil |
| Earnings pS (EPS) | -0.15 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 268,748 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 52.9 | mil |
| Float as % of Shares Outstanding | 74.4 | % |
| Foreign Sales | 124 | mil |
| Domestic Sales | 171 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 48.70 | % |
| Research & Devlopment (R&D) as % of Revenue | 18.40 | % |
| Gross Profit Margin | 71.0 | % |
| EBITDA Margin | 3.9 | % |
| Pre-Tax Profit Margin | -18.5 | % |
| Assets Turnover | 0.7 | % |
| Return on Assets (ROA) | -2.8 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -3.5 | % |
| Current Ratio | 2.2 | |
| Leverage Ratio (Assets/Equity) | 2.0 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.67 | |
| LT Debt/Total Capital | 38.0 | % |
| Working Capital pS | 1.33 | $ |
| Cash pS | 0.53 | $ |
| Book-Value pS | 3.68 | $ |
| Tangible Book-Value pS | -0.60 | $ |
| Cash Flow pS | 0.54 | $ |
| Free Cash Flow pS | -4.24 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.01 | |
| Price/Tangible Book Ratio | -6.19 | |
| Price/Cash Flow | 6.9 | |
| Price/Free Cash Flow | -0.9 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 1.1 | 101 | 3,728 | 4,678 |
| 4 Weeks | 3.89 | 3.22 | 3.45 | 8.1 | 102 | 5,192 | 88,263 |
| 13 Weeks | 4.84 | 3.22 | 3.87 | -3.6 | 88 | 6,659 | 406,201 |
| 26 Weeks | 4.84 | 3.05 | 3.49 | 6.9 | 90 | 6,992 | 853,065 |
| 52 Weeks | 5.50 | 2.96 | 4.96 | -24.8 | 59 | 8,470 | 2,083,589 |
| YTD | 4.84 | 3.22 | - | 17.7 | 101 | 7,231 | 701,390 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 3.72 | 3.75 | 3.99 | 3.73 | 3.78 | 2.17 | 1.07 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -8.44 | 75.7 | -3.05 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 9.85 | NA | 176.10 |
| R&D | -6.28 | NA | -8.14 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 19.5 | 19.5 | 10.5 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | -0.16 | -0.16 | 0.25 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 17.89 |
| Current Ratio | 2.3 |
| Quick Ratio (Acid Test) | 1.2 |
| Liquidity Ratio (Cash) | 0.47 |
| Receivables Turnover | 6.0 |
| Average Collection Period | 60 |
| Working Capital/Equity | 35.1 |
| Working Capital pS | 1.37 |
| Cash-Flow pS | 0.49 |
| Free Cash-Flow pS | -4.43 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 1.04 |
| Financial Leverage Ratio (Assets/Equity) | 2.0 |
| Debt Ratio | 49.1 |
| Total Debt/Equity (Gearing Ratio) | 0.66 |
| LT Debt/Equity | 0.60 |
| LT Debt/Capital Invested | 43.3 |
| LT Debt/Total Liabilities | 62.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 1.53 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 7.24 |
| Tobin's Q Ratio | 0.49 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | 60.08 |
| Enterprise Value (EV)/Free Cash Flow | -1.67 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -6.19 |
| Price/Book Ratio - LTM | 1.01 |
| Price/Cash Flow Ratio | 6.9 |
| Price/Free Cash Flow Ratio - LTM | -0.9 |
| Price/Sales Ratio | 0.86 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 2.33 |
| Current Liabilities pS | 1.06 |
| Tangible Book Value pS - LTM | -0.60 |
| Book Value pS - LTM | 3.68 |
| Capital Invested pS | 6.23 |
| Cash pS - LTM | 0.53 |
| Cash Flow pS - LTM | 0.54 |
| Free Cash Flow pS - LTM | -4.24 |
| Earnings pS (EPS) | -0.15 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -106.42 |
| Free Cash Flow Margin 5YEAR AVG | -20.82 |
| Net Profit Margin | -3.6 |
| Net Profit Margin - 5YEAR AVRG. | -23.6 |
| Equity Productivity | 1.07 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 0.67 |
| Return on Capital Invested (ROCI) | -2.4 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -16.1 |
| Assets Productivity | 0.60 |
| Return on Assets (ROA) | -2.0 |
| Return on Assets (ROA) - 5YEAR AVRG. | -13.7 |
| Gross Profit Margin | 71.0 |
| Gross Profit Margin - 5YEAR AVRG. | 71.2 |
| EBITDA Margin - LTM | 3.9 |
| EBIT Margin - LTM | -15.5 |
| Pre-Tax Profit Margin | -15.7 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -21.6 |
| Effective Tax Rate | 77.0 |
| Effective Tax Rate - 5YEAR AVRG. | 3.7 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 306 |
| Revenue per Employee | 268,748 |
| Net Income per Employee | -9,724 |
| Average Collection Period | 66 |
| Receivables Turnover | 6.0 |
| Day's Inventory Turnover Ratio | 240 |
| Inventory Turnover | 1.5 |
| Inventory/Sales | 24.6 |
| Accounts Payble/Sales | 4.64 |
| Assets/Revenue | 1.67 |
| Net Working Capital Turnover | 3.04 |
| Fixed Assets Turnover | 0.80 |
| Total Assets Turnover | 0.6 |
| Revenue per $ Cash | 11.52 |
| Revenue per $ Plant | 10.31 |
| Revenue per $ Common Equity | 1.07 |
| Revenue per $ Capital Invested | 0.67 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 48.3 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 38.8 |
| Research & Devlopment (R&D) as % of Revenue | 19.6 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 19.6 |
|
|  
|
| |
 |  |
